Request Quote
Kingphar Medical Group

New's

 6/4 2026

Table of Contents

EU MDR 2017/745 for Medical Consumables: What Chinese Exporters Need to Know 2026
Regulatory Compliance · EU MDR Guide

EU MDR 2017/745 for Medical
Consumables: What Chinese
Exporters Need to Know 2026

The EU Medical Device Regulation (MDR 2017/745) replaced the old MDD in May 2024. For Chinese manufacturers of gauze, bandages, wound dressings, and surgical consumables, this means stricter technical documentation, mandatory notified body involvement for sterile products, and new post-market obligations. This guide covers everything that matters for consumable manufacturers.

MDD vs MDR differences Device classification Notified body requirements EU AR requirement Technical documentation EUDAMED registration
A
Albar
Content Auditor & Content Operations · Kingphar Medical
MDD expiry date
May 2024
MDD CE certificates expired 26 May 2024 — only MDR certificates now accepted for EU supply
Regulation reference
2017/745
EU Regulation 2017/745 — applies across all 27 EU member states + EEA (Norway, Iceland, Liechtenstein)
EU AR requirement
Mandatory
Non-EU manufacturers must appoint an EU Authorized Representative before CE marking
Sterile consumables class
IIa
Sterile gauze, bandages, surgical drapes — require notified body CE certificate

EU MDR 2017/745 is the European Union's medical device regulatory framework that replaced the Medical Device Directive (MDD 93/42/EEC) in May 2021, with a transition period that ended on 26 May 2024. For Chinese manufacturers of medical consumables — gauze, bandages, wound dressings, first aid kits, surgical consumables — MDR compliance is now the only pathway to CE marking and European market access.

The shift from MDD to MDR is not simply a paperwork update. MDR imposes substantially higher requirements for clinical evidence, technical documentation, post-market surveillance, and manufacturing quality systems. Many Chinese consumable manufacturers who held MDD CE certificates are still in the process of completing MDR transition — and without a valid MDR CE certificate, their products cannot legally enter European markets or be used as supporting documentation for SFDA registration in Saudi Arabia.

If your CE certificate still references MDD 93/42/EEC — it is no longer valid

As of 26 May 2024, CE certificates issued under MDD 93/42/EEC are expired. If your CE certificate references "Council Directive 93/42/EEC" rather than "Regulation (EU) 2017/745", you cannot legally place your products on the EU market. Buyers in Europe, GCC, and other markets that require EU CE as a qualification criterion will reject MDD certificates. Contact your notified body immediately if you have not completed MDR transition.


Section 01

MDD vs MDR: Key Differences for Consumable Manufacturers

RequirementMDD (expired)MDR 2017/745 (current)
Legal instrumentDirective — implemented differently by each EU countryRegulation — directly applicable in all EU member states, uniform rules
Device classification4 classes (I, IIa, IIb, III)4 classes (I, IIa, IIb, III) — same structure but reclassification rules changed; some devices moved to higher class
Clinical evidenceEquivalence claims widely accepted — could reference competitor dataStricter — equivalence much harder to claim; own clinical data increasingly required
Technical documentationTechnical File — less structuredTechnical Documentation — more detailed; must include clinical evaluation report (CER)
Post-market surveillanceBasic requirementsMandatory PMS plan, PMCF (Post-Market Clinical Follow-up) for most devices, periodic safety update reports (PSUR)
EU Authorized RepresentativeRequired for non-EU manufacturersRequired — now also registered in EUDAMED with expanded responsibilities
UDI (Unique Device Identification)Not requiredMandatory for all devices — UDI-DI and UDI-PI on device and packaging
EUDAMED registrationNot requiredMandatory — devices and manufacturers must be registered
Notified body involvementRequired for Class I sterile, IIa, IIb, IIISame classes, but notified body scrutiny is more intensive — more audits, more documentation review
Summary of Safety and Clinical Performance (SSCP)Not requiredRequired for Class III and implantable devices — publicly available document

Section 02

Device Classification: Where Do Medical Consumables Fall?

MDR classification is based on risk — the intended use, duration of contact, invasiveness, and whether the device is sterile or contains active components. For medical consumables, the key classification rules are:

Lowest Risk
Class I
Non-invasive, non-sterile devices with no or minimal patient contact risk. Self-certified by manufacturer — no notified body required for non-sterile, non-measuring Class I.
Non-sterile gauze rolls, non-sterile bandages, non-sterile cotton wool, non-sterile wound dressings, first aid kit containers (non-medical contents)
Self-certify (non-sterile)
Class I — Special
Class Is / Im
Class I devices supplied in sterile state (Is) or with a measuring function (Im) require notified body involvement for the sterility or measuring aspects, even though the device itself is Class I.
Sterile non-medicated gauze swabs, sterile bandages, sterile wound dressings supplied ready for use
Notified body required
Low-Medium Risk
Class IIa
Devices intended for short-term use in an active healing role, or with patient contact characteristics beyond simple coverage. Require full notified body CE certificate.
Surgical drapes, isolation gowns, laparotomy sponges (sterile, X-ray detectable), advanced wound dressings, paraffin gauze (sterile)
Notified body required
Medium-High Risk
Class IIb
Devices with higher patient contact risk, longer duration, or with specific active characteristics. More intensive notified body review required.
Antimicrobial wound dressings (silver, PHMB), negative pressure wound therapy components, some advanced dressings with active components
Notified body required

Classification of common Kingphar products under MDR

  • Non-sterile woven gauze swabs / rolls / bandages → Class I (self-certify)
  • Sterile woven gauze swabs → Class Is (notified body for sterility aspect)
  • Sterile paraffin gauze → Class IIa (notified body required)
  • Surgical drapes and gowns → Class IIa (notified body required)
  • Laparotomy sponges (X-ray detectable) → Class IIa (notified body required)
  • First aid kits (contents determine classification) → Depends on contents — typically Class I or mixed

Section 03

The EU Authorized Representative: What You Need

Under MDR Article 11, any manufacturer established outside the EU/EEA must appoint an EU Authorized Representative (EU AR) before CE marking their device. The EU AR is a legal requirement — not optional — and cannot be replaced by an importer or distributor unless they also hold formal EU AR designation.

What the EU AR must do

  • Register in EUDAMED as the EU AR for your devices
  • Ensure your technical documentation and Declaration of Conformity are in order
  • Register your devices and UDI codes in EUDAMED
  • Act as the contact point for EU regulatory authorities (national competent authorities)
  • Cooperate with market surveillance authorities
  • Notify competent authorities of serious incidents and field safety corrective actions
  • Maintain a copy of your technical documentation for a minimum of 10 years after last device manufactured
EU AR liability under MDR is significantly higher than under MDD

Under MDR, the EU AR shares legal responsibility with the manufacturer for device compliance. This means EU AR companies now conduct more thorough due diligence on manufacturers before accepting appointment — including reviewing ISO 13485 certificates, quality management systems, and technical documentation. Simply paying an EU AR fee without providing complete technical documentation is no longer sufficient. Budget for a genuine compliance relationship, not just an administrative service.


Section 04

Technical Documentation: What MDR Requires

MDR Annex II and Annex III define the Technical Documentation requirements. For medical consumables, the key elements are:

1

Device description and specification

Complete description of the device including intended purpose, materials, dimensions, packaging, and all variants covered by the documentation. For gauze products, this includes thread count, fiber content, ply count, size range, sterility status, and sterilization method.

2

Information to be supplied by the manufacturer (labeling)

Full labeling including IFU (Instructions for Use) for all markets. MDR requires labeling in the official language(s) of each EU member state where the device is sold — this is a significant change from MDD practice where English-only was often accepted.

3

Design and manufacturing information

Complete information about manufacturing processes, quality control steps, sterilization validation (for sterile products), and supply chain including key raw material suppliers. Under MDR, regulators have the right to audit manufacturing sites directly — not just review documentation.

4

General Safety and Performance Requirements (GSPR)

A checklist demonstrating compliance with every applicable GSPR from MDR Annex I. For consumables, key requirements include biocompatibility (ISO 10993), sterility validation (ISO 11135/11137), packaging integrity (ISO 11607), and chemical safety of materials and processing agents.

5

Benefit-risk analysis and risk management

Risk management file per ISO 14971 — identifying hazards, assessing risks, implementing risk controls, and demonstrating that residual risks are acceptable. MDR places more emphasis on this than MDD did.

6

Clinical Evaluation Report (CER)

The CER is one of the most demanding new requirements under MDR. It must systematically review clinical data — including published literature, clinical investigations, and post-market data — to demonstrate clinical safety and performance. For well-established consumables like gauze, a literature-based CER using published wound care studies is typically acceptable, but the CER must be substantially more rigorous than MDD equivalence claims.

7

Post-Market Surveillance (PMS) plan

A documented plan for collecting and analyzing post-market data — complaint records, vigilance reports, literature surveillance, and PMCF (Post-Market Clinical Follow-up) where applicable. The PMS plan must be active and updated — not a static document created at certification time.


Section 05

EUDAMED and UDI: New Requirements for Chinese Manufacturers

EUDAMED registration

EUDAMED (European Database on Medical Devices) is the EU's centralized medical device database. Under MDR, manufacturers must register through their EU AR in EUDAMED before placing devices on the EU market. Registration covers the manufacturer entity, the EU AR, and individual device registrations with UDI codes.

UDI — Unique Device Identification

MDR mandates UDI for all medical devices. UDI consists of two components — UDI-DI (device identifier, identifying the specific product) and UDI-PI (production identifier, including lot/batch number and expiry date). For gauze and bandages, UDI labeling requirements mean:

  • A UDI carrier (barcode or RFID) must appear on the device label and packaging
  • The UDI-DI must be registered in EUDAMED
  • For Class I non-sterile devices — UDI-DI on label, no EUDAMED upload required initially
  • For Class IIa and above — UDI-DI on label plus EUDAMED registration required

Practical UDI implementation for consumable manufacturers

The most common UDI carrier for medical consumables is a GS1 barcode (GS1-128 or GS1 DataMatrix). You will need a GS1 company prefix to generate your own UDI codes — register at gs1.org. Your EU AR can assist with EUDAMED UDI registration. For high-volume consumables like gauze swabs, the UDI is typically applied at the secondary (box) packaging level, with a simplified label on individual sterile packs.


Section 06

MDR Compliance Checklist for Chinese Consumable Manufacturers

  • Confirm your CE certificates reference MDR 2017/745 — not MDD — check the regulation reference on every CE certificate. Any reference to "93/42/EEC" means the certificate is expired and must be replaced.
  • Appoint an EU Authorized Representative — the EU AR must be established in an EU/EEA country and registered in EUDAMED. Budget for a genuine compliance relationship including technical documentation review.
  • Confirm device classification under MDR classification rules — reclassification has affected some devices; sterile consumables that were Class I under MDD may now require notified body involvement under MDR.
  • Engage a notified body for Class Is, IIa, IIb, and III devices — notified bodies are increasingly busy post-MDD expiry; initiate notified body engagement early as wait times have increased significantly since 2024.
  • Prepare MDR-compliant Technical Documentation including CER — the Clinical Evaluation Report is the most commonly deficient element in MDR submissions from Chinese manufacturers; engage a clinical evaluator with MDR experience.
  • Implement ISO 14971 risk management — the risk management file must be updated throughout the product lifecycle, not created once at certification time.
  • Register in EUDAMED and assign UDI codes — obtain a GS1 company prefix, generate UDI codes for each device variant, register in EUDAMED through your EU AR.
  • Update labeling for multi-language EU requirements — MDR requires labeling in official language(s) of each EU member state where the device is sold. At minimum, ensure English, French, German, Spanish, Italian, and Polish are covered for broad EU market access.
  • Establish an active Post-Market Surveillance system — PMS is not a static document. You must actively collect complaint data, literature, and vigilance information and document it in regular PMS reports and PSURs.

Related guides

Continue reading

Sourcing CE-certified medical consumables for European markets?

Kingphar holds CE marking under EU MDR 2017/745 and ISO 13485 certification for gauze, bandages, surgical consumables, and first aid kits — with full MDR-compliant technical documentation and active post-market surveillance.

A
Albar
Content Auditor & Content Operations · Kingphar Medical

Frequently Asked Questions: Gauze Selection

Q: Can I use standard gauze for a heavily draining wound?

A: While possible, standard 19x15 mesh will saturate quickly, leading to maceration of the surrounding skin. For heavy exudate, we strongly recommend 28x24 high-density mesh or increasing the ply count to 12-ply to utilize its superior capillary pressure.

Q: What is the difference between Type VII and Type III gauze?

A: Type VII (20x12) is the standard for most surgical sponges, offering a balance of absorbency and debris removal. Type III (28x24) is finer, used for delicate tissues or where higher fluid retention is required.

Q: Why should I choose X-Ray detectable sponges for all surgeries?

A: Using X-Ray detectable (XR) gauze for all invasive procedures eliminates the risk of mixing up sterile supplies. It provides a universal safety net against Retained Surgical Items (RSI), a critical patient safety indicator.